What is BEAT's current stock price?

BEAT (HeartBeam, Inc.) is currently trading at $0.89 with a market cap of $30.5M.

What sector is HeartBeam, Inc. in?

HeartBeam, Inc. (BEAT) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.

Is BEAT a good stock to buy?

Analysts have a Buy consensus on BEAT with a price target of $5.50. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

BEAT HeartBeam, Inc.

Healthcare

$0.89+0.00%OpenMarket Cap: $30.5M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

56.16

P/S

0.00

EV/EBITDA

-1.39

DCF Value

$0.13

FCF Yield

-46.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-1034.0%

ROA

-514.9%

ROIC

-3205.2%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$0.00	$-4.7M	$—
Q4 null	$0.00	$-5.3M	$—
FY null	$0.00	$-21.0M	$—
Q3 null	$0.00	$-5.3M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$5.50

Target (Median)

$5.50

Target Range

$5.50 - $5.50

1 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell

HC Wainwright & Co.Buy

2026-05-22

BenchmarkSpeculative Buy

2026-05-15

D. Boral CapitalBuy

2026-03-30

HC Wainwright & Co.Buy

2026-03-16

BenchmarkBuy

2025-12-11

Trading Activity

Insider Trades

View All

Ferrari Richarddirector

BuyFri Apr 24

Vajdic Branislavdirector

BuyThu Apr 16

STROME MARK Edirector

BuyThu Apr 16

Ortigas-Wedekind Margadirector

BuyThu Apr 16

JAFF MICHAEL Rdirector

BuyThu Apr 16

Company Info

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Country

Exchange

—

Beta

-0.87

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Peers